Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
about
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisRoles of miR-182 in sensory organ development and cancerThe microRNA-183 cluster: the family that plays together stays togetherGenetic variants in regulatory regions of microRNAs are associated with lung cancer riskIdentification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinomaMicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinomaTissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?Prognostic Value of MicroRNA-182 in Cancers: A Meta-AnalysisMicroRNA-182 prevents vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ signaling.miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC.MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value.MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasiaMicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.Transcriptional and Posttranscriptional Upregulation of p27 Mediates Growth Inhibition of Isorhapontigenin (ISO) on Human Bladder Cancer Cells.Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
P2860
Q26747871-B092AC46-7C52-4834-9718-E6E40DD23D70Q26798264-98E019BD-21B3-456F-A55A-F0A449352970Q28080473-D561140B-80FC-43B5-9ABB-4CB421394AD0Q29248375-9FC908E9-7AE3-46A3-8581-1BD188001E3FQ29248611-F5AF67A9-A428-4340-9880-D8EC5F7A78FAQ34253848-386C4E4C-C245-4717-B4D3-FC1BDA4A8A8AQ35190111-2018AB18-FF65-4BFC-BF63-281CFC567535Q35630616-A7435F14-3D1B-40A3-90F1-AB4185E87F7CQ37714151-B475524F-9932-4468-AF1F-FC64FADDB956Q38962801-269DC851-5125-46BD-A5E8-AC601BCA3944Q41347645-6FD5E7CB-D643-4A68-9EBA-A3B61B777B84Q41860642-B6226D87-B39C-4ACF-9B30-1BCB0F58F807Q47663124-12A3BD05-284F-4CE2-8A90-B8FEC0D7B209Q50161125-16C1E5F5-8D11-4A78-B10B-00ABFF448246Q52595636-F1506A9A-9B91-4320-9BF4-5F9E6A752CEAQ52659539-5DA11BF1-D85D-4854-9C70-62DBDCE26EABQ53048458-75509955-6C11-4217-B8FC-DC75B691A6BB
P2860
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@ast
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@en
type
label
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@ast
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@en
prefLabel
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@ast
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@en
P2093
P2860
P356
P1433
P1476
Stage and tissue-specific prognostic impact of miR-182 in NSCLC.
@en
P2093
Helge Stenvold
Lill-Tove Busund
Roy M Bremnes
Samer Al-Saad
Sigve Andersen
Tom Donnem
P2860
P2888
P356
10.1186/1471-2407-14-138
P407
P577
2014-02-27T00:00:00Z
P5875
P6179
1045953102